Critical role of type III interferon in controlling SARS-CoV-2 infection, replication and spread in primary human intestinal epithelial cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: SARS-CoV-2 is an unprecedented worldwide health problem that requires concerted and global approaches to better understand the virus in order to develop novel therapeutic approaches to stop the COVID-19 pandemic and to better prepare against potential future emergence of novel pandemic viruses. Although SARS-CoV-2 primarily targets cells of the lung epithelium causing respiratory infection and pathologies, there is growing evidence that the intestinal epithelium is also infected. However, the importance of the enteric phase of SARS-CoV-2 for virus-induced pathologies, spreading and prognosis remains unknown. Here, using both colon-derived cell lines and primary non-transformed colon organoids, we engage in the first comprehensive analysis of SARS-CoV-2 lifecycle in human intestinal epithelial cells. Our results demonstrate that human intestinal epithelial cells fully support SARS-CoV-2 infection, replication and production of infectious de-novo virus particles. Importantly, we identified intestinal epithelial cells as the best culture model to propagate SARS-CoV-2. We found that viral infection elicited an extremely robust intrinsic immune response where, interestingly, type III interferon mediated response was significantly more efficient at controlling SARS-CoV-2 replication and spread compared to type I interferon. Taken together, our data demonstrate that human intestinal epithelial cells are a productive site of SARS-CoV-2 replication and suggest that the enteric phase of SARS-CoV-2 may participate in the pathologies observed in COVID-19 patients by contributing in increasing patient viremia and by fueling an exacerbated cytokine response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Replication of human noroviruses in stem cell–derived human enteroids
Ettayebi, K., Crawford, S. E., Murakami, K., Broughman, J. R., Karandikar, U., Tenge, V. R., Neill, F. H., Blutt, S. E., Zeng, X.-L., Qu, L., et al. (2016) · Science · doi:10.1126/science.aaf5211 · Cited by 1,305
Qi, F., Qian, S., Zhang, S., & Zhang, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.03.044 · Cited by 905 · cited 1×
“This is very different to the small intestine where ACE-2 appears to be more expressed (Qi et al., 2020).”
BackgroundSingle-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2
Zhao, Y., Zhao, Z., Wang, Y., Zhou, Y., Ma, Y., & Zuo, W. (2020) · doi:10.1101/2020.01.26.919985 · Cited by 860 · cited 2×
“SARS-CoV-2 infection of the gastrointestinal tract is supported by the fact that ACE2, the virus receptor (Hoffmann et al., 2020) , is expressed in intestinal epithelial cells (Zhao et al., 2020) (Lukassen et al., 2020) (Wu et al., 2020a) (Venkatakrishnan et al., 2020) and single cell sequencing analysis suggest that…”
Background
Research works printed but not linked: 33
- Blanco-Melo, D. , Nilsson-Payant, B.E. , Liu, W.-C. , Møller, R. , Panis, M. , Sachs, D. , Albrecht, R.A. , and tenOever, B.R. 2020. SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems (Microbiology). · DOI
- 10.1371/journal.ppat.1003773 · DOI · Paper page
- 10.1038/s41579-018-0118-9 · DOI · Paper page
- 2015, Ultrastructure of the replication sites of positive-strand RNA viruses, Virology, 479–480, 418
- Harcourt, J. , Tamin, A. , Lu, X. , Kamili, S. , Sakthivel, S.Kumar. , Murray, J. , Queen, K. , Tao, Y. , Paden, C.R. , Zhang, J. , et al. 2020. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient (Microbiology). · DOI
- Hoffmann, M. , Kleine-Weber, H. , Schroeder, S. , Krüger, N. , Herrler, T. , Erichsen, S. , Schiergens, T.S. , Herrler, G. , Wu, N.-H. , Nitsche, A. , et al. 2020. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 0. · DOI · Paper page
- 10.1016/j.gastro.2003.08.001 · DOI · Paper page
- Lokugamage, K.G. , Hage, A. , Schindewolf, C. , Rajsbaum, R. , and Menachery, V.D. 2020. SARS-CoV-2 sensitive to type I interferon pretreatment. BioRxiv 2020.03.07.982264.
- 10.1002/jmv.25678 · DOI · Paper page
- Lukassen, S. , Lorenz Chua, R. , Trefzer, T. , Kahn, N.C. , Schneider, M.A. , Muley, T. , Winter, H. , Meister, M. , Veith, C. , Boots, A.W. , et al. 2020. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. EMBO J. n/a. · DOI · Paper page
- Mantlo, E. , Bukreyeva, N. , Maruyama, J. , Paessler, S. , and Huang, C. 2020. Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection. BioRxiv 2020.04.02.022764. · DOI
- Moriyama, M. , Hugentobler, W.J. , and Iwasaki, A. 2020. Seasonality of Respiratory Viral Infections. Annu. Rev. Virol. 7, null. · DOI · Paper page
- 10.1128/JVI.79.6.3846-3850.2005 · DOI
- 10.1001/jama.2020.0757 · DOI · Paper page
- 10.3389/fimmu.2017.00459 · DOI
- 10.1371/journal.ppat.1007420 · DOI · Paper page
- 10.1073/pnas.1100552108 · DOI · Paper page
- 10.1016/j.cell.2019.06.029 · DOI · Paper page
- 10.1111/cmi.12626 · DOI
- 2020, Asymmetric distribution of TLR3 leads to a polarized immune response in human intestinal epithelial cells, Nat. Microbiol, 5, 181
- 10.1128/JVI.01565-07 · DOI · Paper page
- Venkatakrishnan, A.J. , Puranik, A. , Anand, A. , Zemmour, D. , Yao, X. , Wu, X. , Chilaka, R. , Murakowski, D.K. , Standish, K. , Raghunathan, B. , et al. 2020. Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors. BioRxiv 2020.03.24.005702. · doi:10.1101/2020.03.24.005702
- Wang, L. , and Zhang, Y. 2016. Animal Coronaviruses: A Brief Introduction. In Animal Coronaviruses, L. Wang , ed. (New York, NY: Springer), pp. 3–11. · doi:10.1007/978-1-4939-3414-0_1
- 10.1016/j.coviro.2018.12.001 · DOI · Paper page
- Wang, W. , Xu, Y. , Gao, R. , Lu, R. , Han, K. , Wu, G. , and Tan, W. 2020. Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA. · DOI · Paper page
- Wölfel, R. , Corman, V.M. , Guggemos, W. , Seilmaier, M. , Zange, S. , Müller, M.A. , Niemeyer, D. , Jones, T.C. , Vollmar, P. , Rothe, C. , et al. 2020. Virological assessment of hospitalized patients with COVID-2019. Nature. · DOI
- Wu, C. , Zheng, S. , Chen, Y. , and Zheng, M. (2020a). Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue (Infectious Diseases (except HIV/AIDS)). · DOI
- Wu, Y. , Guo, C. , Tang, L. , Hong, Z. , Zhou, J. , Dong, X. , Yin, H. , Xiao, Q. , Tang, Y. , Qu, X. , et al. (2020b). Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol. Hepatol. 0. · DOI · Paper page
- Xiao, F. , Tang, M. , Zheng, X. , Liu, Y. , Li, X. , and Shan, H. 2020. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology S0016508520302821. · DOI · Paper page
- Xing, Y.-H. , Ni, W. , Wu, Q. , Li, W.-J. , Li, G.-J. , Wang, W.-D. , Tong, J.-N. , Song, X.-F. , Wing-Kin Wong, G. , and Xing, Q.-S. 2020. Prolonged Viral Shedding in Feces of Pediatric Patients with Coronavirus Disease 2019. J. Microbiol. Immunol. Infect. S1684118220300815. · DOI · Paper page
- Xu, Y. , Li, X. , Zhu, B. , Liang, H. , Fang, C. , Gong, Y. , Guo, Q. , Sun, X. , Zhao, D. , Shen, J. , et al. (2020b). Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding. Nat. Med. 1–4. · DOI · Paper page
- 10.1038/s41590-019-0345-x · DOI
- 10.1126/sciadv.aao4966 · DOI · Paper page
Cited by
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
Zang, R., Castro, M. F. G., McCune, B. T., Zeng, Q., Rothlauf, P. W., Sonnek, N. M., Liu, Z., Brulois, K. F., Wang, X., Greenberg, H. B., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc3582 · Cited by 982
“that examined SARS-CoV-2 infection of human IECs (51, 52).”
BackgroundInfluentialType I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909
Interplay between SARS-CoV-2 and the type I interferon response
Sa Ribero, M., Jouvenet, N., Dreux, M., & Nisole, S. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008737 · Cited by 443
Onabajo, O. O., Banday, A. R., Stanifer, M. L., Yan, W., Obajemu, A., Santer, D. M., Florez-Vargas, O., Piontkivska, H., Vargas, J. M., Ring, T. J., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00731-9 · Cited by 261
Self-citationCholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
Zang, R., Case, J. B., Yutuc, E., Ma, X., Shen, S., Gomez Castro, M. F., Liu, Z., Zeng, Q., Zhao, H., Son, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012197117 · Cited by 240
Nchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio · doi:10.1128/mbio.01930-20 · Cited by 146
Metadata
- Authors
- Stanifer, M. L., Kee, C., Cortese, M., Triana, S., Mukenhirn, M., Kraeusslich, H.-G., Alexandrov, T., Bartenschlager, R., & Boulant, S.
- Venue
- bioRxiv (Cold Spring Harbor Laboratory)
- Publisher
- openRxiv
- Published
- 2020-04-24
- OpenAlex
- W3019118275
- Cited by
- 40
- References
- 4
- Type
- posted content
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.